Effect of Buzzy® Application on Pain During Subcutaneous Application in Children*

INTRODUCTION: Reducing children’s pain during medical procedures is important for their response to painful procedures later in life and for their acceptance of medical care. This study was conducted to determine the efficacy of the Buzzy® device used in subcutaneous administration to hospitalized or outpatient children in pediatric oncology immunology. The combination of vibration and ice physiologically suppresses the body’s pain nerves and provides natural pain relief within seconds.
METHODS: The study, conducted as a quasi-experimental single-group pretest–post-test design, was completed with 26 children aged 6-18 years. In this study, Introductory Information Form, Application Registration Form, Wong-Baker Faces Pain Scale, and Visual Analog Scale were used. For experimental application, Buzzy® was placed 3-5 cm above the injection site 30 seconds prior to subcutaneous application and then the subcutaneous application was performed. Paired samples t-test and Wilcoxon test were used to analyze the data.
RESULTS: It was found that children experienced less pain when administered subcutaneously with the Buzzy® device (P = .0001). In addition, although there was no significant difference in mean saturation and blood pressure between the control and experimental
applications in the children (P >.05), there was a significant difference in mean pulse rate (P = .012) and respiratory rate (P = .003).
DISCUSSION AND CONCLUSION: The application of Buzzy® in reducing pain in children during subcutaneous application was found to be an effective method.